The Oncology Institute, Inc.
TOI
$2.71
$0.3213.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.37% | 1.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.37% | 1.34% | |||
| Cost of Revenue | 0.11% | -0.02% | |||
| Gross Profit | 1.88% | 10.29% | |||
| SG&A Expenses | -6.71% | -4.40% | |||
| Depreciation & Amortization | 8.52% | 3.62% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.37% | -1.03% | |||
| Operating Income | 13.89% | 15.34% | |||
| Income Before Tax | 18.19% | -4.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.19% | -4.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.19% | -4.10% | |||
| EBIT | 13.89% | 15.34% | |||
| EBITDA | 16.76% | 17.28% | |||
| EPS Basic | 18.28% | -3.24% | |||
| Normalized Basic EPS | 15.81% | -2.87% | |||
| EPS Diluted | 18.50% | -5.88% | |||
| Normalized Diluted EPS | 15.81% | -2.87% | |||
| Average Basic Shares Outstanding | 0.17% | 1.04% | |||
| Average Diluted Shares Outstanding | 0.17% | 1.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||